Rafia Al-Lamki, B.S. (Hons), MPhil, and Ph.D., serves as a clinical scientist. Al-Lamki's areas of expertise include cellular pathology, cell death pathways, renal injury, stem cells, cell imaging, TNF biology, endothelial dysfunction, and immunology. Al-Lamki is a Fellow Member at The Institute of Biomedical Sciences, London, the Royal Microscopy Society (FRMS), Oxford, Cambridge Philosophical Society (FCPS), University of Cambridge, The Cambridge Commonwealth Society (FCCS), University of Cambridge, and Kidney Research UK. Al-Lamki also serves as a Reviewer in the Journal of Nephrology, Journal of Immunology, PLOS One, and Human Reproduction. Al-Lamki's recent publications include "Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension," "DR3 signaling protects against cisplatin nephrotoxicity mediated by tumor necrosis factor," and "Reperfusion injury intensifies the adaptive human T-cell alloresponse in a human-mouse chimeric artery model."
Biography Updated on 30 April 2013